Michael Michael — ASN Events

Michael Michael — ASN Events

Michael Michael

Peter MacCallum Cancer Centre, VIC, Australia

This delegate is presenting an abstract at this event.

Prof Michael Michael is a consultant Gastrointestinal and Neuroendocrine medical oncologist at the Peter MacCallum Cancer Centre. He has strong academic interest in novel combined modality therapies in these cancers. He also has a significant track record in clinical pharmacology/pharmacogenomics, with a focus on individualising systemic therapy dosing and toxicity prediction.

Presentations this author is a contributor to:

Symptom burden of Australia and New Zealand (ANZ) patients with Neuroendocrine Tumours (NET) (#348)

Experience of Australia and New Zealand (ANZ) patients with neuroendocrine tumours (NET) treated at a NET specialist centre: Results of a national survey and the Royal North Shore experience (#350)

NET Care in Australia; The patient’s perspective of their Neuroendocrine Tumours (NET) and impact of diagnosis (#374)

Neuroendocrine tumor (NET) Oceania patient experience: results from the first global NET patient survey - A collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis (#74)

Best of the Best Orals - Rare Cancers

Management of Hypertensive Crisis in Paraganglioma-A Case Report (#368)